Found 24 matching trials
Pre-Operative Treatment in REseCTable COlon CanceR
PHASE3This is an open-label, randomized, controlled, multicenter, phase III study...
Location
Charité Universitätsmedizin Berlin
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
PHASE4To evaluate the efficacy and safety of immune checkpoint inhibitor-based co...
Location
Fudan University Shanghai Cancer Center
Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)
PHASE3This study is designed to evaluate the efficacy and safety of adjuvant hype...
Location
Fudan University Shanghai Cancer Center
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
PHASE2The goal of this open-label randomized, multicenter, comparative phase II t...
Location
Institut de Cancérologie de l'Ouest
Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer
PHASE2It has been reported that the immune status of patients with cancer were su...
Location
Guangdong Provincial Hospital of Chinese Medicine
COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer
EARLY_PHASE1This is an early phase I, single-arm, open-label clinical study designed to...
Location
Biogenea Pharmaeuticals Ltd
5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
PHASE2This phase II trial will investigate the combination of adjuvant 5-fluorour...
Location
Northeast Alabama Regional Medical Center
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
PHASE2This is a prospective, randomized, open-label, two-arm phase 2 trial that w...
Location
Froedtert & the Medical College of Wisconsin
A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
PHASE2A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Location
Mayo Clinic Cancer Center
Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy
PHASE3This study is designed to confirm that first 3 months of oxaliplatin in 6 m...
Location
Hallym University Medical Center